1561. Omadacycline Pharmacokinetics: Influence of Mortality Risk Score Among Patients with Community-Acquired Bacterial Pneumonia

BACKGROUND: Omadacycline is a novel aminomethylcycline with activity against Gram-positive and -negative organisms, including tetracycline-resistant pathogens. Omadacycline was recently approved in the United States for treatment of adult patients with community-acquired bacterial pneumonia (CABP) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakota, Elizabeth A, Friedrich, Lawrence, Steenbergen, Judith N, McGovern, Paul C, Tzanis, Evan, Bhavnani, Sujata M, Rubino, Christopher M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809138/
http://dx.doi.org/10.1093/ofid/ofz360.1425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809138/
http://dx.doi.org/10.1093/ofid/ofz360.1425

Ejemplares similares